DRUSOLV Trademark

Trademark Overview

On Tuesday, August 29, 2017, a trademark application was filed for DRUSOLV with the United States Patent and Trademark Office. The USPTO has given the DRUSOLV trademark a serial number of 87588109. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, October 1, 2025. This trademark is owned by Drusolv Therapeutics, Inc.. The DRUSOLV trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of the treatment and prevention of macular degeneration and other eye diseases; medical and scientific research related to the development of pharmaceutical preparations for the treatment and prevention of macular degeneration and other eye diseases
drusolv

General Information

Serial Number87588109
Word MarkDRUSOLV
Filing DateTuesday, August 29, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, October 1, 2025
Registration Number5764343
Registration DateTuesday, May 28, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesMedical and scientific research in the field of the treatment and prevention of macular degeneration and other eye diseases; medical and scientific research related to the development of pharmaceutical preparations for the treatment and prevention of macular degeneration and other eye diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 6, 2017
Primary Code042
First Use Anywhere DateMonday, August 14, 2017
First Use In Commerce DateMonday, August 14, 2017

Trademark Owner History

Party NameDrusolv Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19102
Party NameDrusolv Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19102
Party NameDrusolv Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19102

Trademark Events

Event DateEvent Description
Friday, September 1, 2017NEW APPLICATION ENTERED
Wednesday, September 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 4, 2017ASSIGNED TO EXAMINER
Tuesday, December 5, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 5, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 16, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2018ASSIGNED TO LIE
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 16, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 26, 2018SOU EXTENSION 1 FILED
Thursday, December 27, 2018TEAS PETITION TO REVIVE RECEIVED
Thursday, December 27, 2018PETITION TO REVIVE-GRANTED
Thursday, December 27, 2018SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, December 28, 2018NOTICE OF REVIVAL - E-MAILED
Monday, February 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 25, 2019SOU EXTENSION 1 GRANTED
Wednesday, April 10, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, April 10, 2019SOU EXTENSION 2 FILED
Wednesday, April 10, 2019USE AMENDMENT FILED
Wednesday, April 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 12, 2019SOU EXTENSION 2 GRANTED
Friday, April 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Saturday, April 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2019SOU TEAS EXTENSION RECEIVED
Thursday, April 25, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 13, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 28, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 28, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 23, 2025TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 1, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 1, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 1, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, September 13, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

drusolv medical degeneration other diseases prevention macular treatment research scientific preparations